Page 37 - Eshre 2018
P. 37
Abteilung Gynäkologische Endokrinologie und Reproduktionsmedizin, Bern
Efficacy
von Wolff et al., 2009, Fertil Steril
Buendgen et al., 2013, Arch Gynecol Obstet
Cakmak et al. 2013 Fertil Steril
Kim et al., 2015 JKMS
von Wolff et al. Eur J Obstet Gynecol Reprod Biol 2016
Foll. phase
Luteal phase
Foll. phase
Luteal phase
Foll. phase
Luteal phase
Foll. phase
Luteal phase
Foll. phase
Luteal phase
Cycles (n)
28
12
30
10
103
22
6
5
472
103
Stim. (d)
10.6
11.4
9.1
11.7
9.3
11.2
11.8
12.3
10.8
11.5
Stim. (U)
2255
2720
2040
3500
3400
4340
1500
2100
2496
2970
Stim/d(U)*
172
238
224
299
365
387
127
170
231
258
Oocyt. (n)
13.1
10.0
10.0
8.8
14.4
15.5
11.5
9.0
11.6
13.6
MII (n)
11.0
8.0
7.9
7.2
9.7
10.3
4.5
6
Fert. Oocytes
*6.7
**6.1
**4.8
**4.6
**7.0
**9.1
10
5
Preg.Rate Cycle
20%
10%
* calculated ** estimated
Michael von Wolff
Abteilung Gynäkologische Endokrinologie und Reproduktionsmedizin, Bern
Indication
• In women before gonadotoxic therapies.
• In any women to reduce treatment time and if freeze all is planned.
Michael von Wolff
Page 31 of 135
PRECONGRESS COURSE 16 I BARCELONA, SPAIN – 1 JULY 2018 37
